MIFH
FLGT icon

Migdal Insurance & Financial Holdings’s Fulgent Genetics FLGT Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15,896
Closed -$1.54M – 617
2021
Q1 		$1.54M Buy
15,896
+9,865
+164% +$1.02M 0.02% 212
2020
Q4 		$314K Buy
+6,031
New +$252K ﹤0.01% 253

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Migdal Insurance & Financial Holdings's FLGT Position: Q2 2021 in Review

Migdal Insurance & Financial Holdings sold out of Fulgent Genetics (FLGT) in Q2 2021, closing a stake of 15,896 shares — an estimated $1.54M sold.

Migdal Insurance & Financial Holdings first reported a position in FLGT in Q4 2020 and held it in 2 quarters. The position peaked at $1.54M in Q1 2021. 254 funds tracked by Wall St. Rank hold FLGT as of Q2 2021.

  • Migdal Insurance & Financial Holdings reported no remaining Fulgent Genetics position as of Q2 2021 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 15,896 Fulgent Genetics shares in Q2 2021, an estimated $1.54M.
  • Migdal Insurance & Financial Holdings first reported a position in Fulgent Genetics in Q4 2020 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's Fulgent Genetics position peaked at $1.54M in Q1 2021.
  • 254 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2021.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.